McKesson logo

Oncology & Specialty Solutions

Accelerating Promising Therapies and Access to Care

It’s an unprecedented time for patients living with cancer and other chronic illnesses as life sciences companies race to create new, cutting-edge therapies, and patients struggle to navigate the challenges and complexity of their care. 

As a leading distributor of oncology and specialty medicines, we provide end-to-end services across the drug lifecycle and ensure therapies make their way to those who are counting on them. 
  
 Our portfolio of oncology solutions aims to address hurdles throughout every stage of the clinical process and improve outcomes by accelerating drug development and clinical trial activation, expanding access to cancer care closer to home and delivering real-world data and 
evidence to advance care.

 

Our Oncology & Specialty Portfolio

Advancing oncology research and care

Ontada

Ontada

Harnessing technology and insights to transform the fight against cancer.

Improving therapy, access and patient outcomes

Genospace

Genospace

Innovating precision medicine to improve patient outcomes by enabling clinical trial matching.

A distribution center.

Pharmaceutical Distribution Services

As the #1 distributor of oncology, rheumatology and gastroenterology products, we offer the expertise to manage through logistical challenges like cold chain requirements, regulatory compliance, dispensing support and more.

Learn More

Oncology & Specialty Health at a Glance

We offer expertise that physicians can rely on to support critical treatment options.

 

15%

Practices in The US Oncology Network treat over 15% of all new cancer patients each year, bringing high-quality care to anyone facing a diagnosis.

1k+

Through SCRI, we are actively enrolling patients to more than 1,000 cancer-focused trials each year.

80k+

We’ve supported over 80,000 patients in more than 1,600 clinical trials.

200+

We offer hundreds of oncology and rare disease therapies — some exclusively —  to treat cancer and its side effects.

Advancing Cancer Care

Today, one in two men and one in three women will be diagnosed with cancer during their lifetime. That’s why together with our partners, we offer research, insights, technologies and services that assist providers and biopharma companies in navigating the intricacies of advancing cancer care.

Who We Serve

We provide oncology and specialty support across the healthcare spectrum.

Life Sciences Companies

  • Biopharma
  • Biotech
  • Biomedical
  • Pharmaceuticals

Healthcare Settings

  • Health Systems
  • Independent Community Practices
  • Specialty Pharmacies

Specialty Practices

  • Oncology
  • Retina
  • Rheumatology
  • Gastroenterology
  • Neurology
Person in a lab coat adjusts an IV bag in a clean, sterile medical environment.
 

The Oncology Drug and Care Journeys

We partner with biopharma to accelerate oncology innovation — every step of the way. See how our connected businesses support the drug development lifecycle and the patient care experience. From discovery and clinical trials to treatment access, real-world insights and survivorship, we help bring therapies to market faster and support providers in delivering personalized care that improves outcomes for patients.

Explore the Journeys
Stories
 

Explore Our Oncology & Specialty Stories and Insights

Discover our oncology and specialty stories, from business insights to employee spotlights and more.

A person stands beside a large moose antler sculpture in a wooded park.
A Remarkable Journey: Conquering Stage IV Cancer

Read More

Three people sit on a stage discussing under a "STAT@ASH" sign, with a presentation screen nearby.
Unlocking the Potential and Promise of Precision Medicine in Cancer Care

Read More

A doctor with a stethoscope is consulting with a seated woman in a bright office.
Expanding Access to Cell and Gene Therapy for Patients

Read More

Overcoming Access Challenges in Cancer Care

Read More

See More Stories
News
 

Explore Our Oncology & Specialty News

Check out the latest news covering our expanding footprint, newest FDA approvals, research results and more.

See More News